Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,932,355
- Total 13F shares
- 18,632,401
- Share change
- -591,017
- Total reported value
- $703,886,639
- Put/Call ratio
- 34%
- Price per share
- $37.78
- Number of holders
- 161
- Value change
- -$18,569,388
- Number of buys
- 63
- Number of sells
- 82
Quarterly Holders Quick Answers
What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05464T104:
Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
5.4%
|
2,656,885
|
$87,572,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.2%
|
2,068,063
|
$68,165,000 | — | 30 Sep 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.3%
|
1,616,497
|
$53,280,000 | — | 30 Sep 2021 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
2.9%
|
1,423,653
|
$46,924,000 | — | 30 Sep 2021 | |
| ALETHEA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,132,645
|
$37,332,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
785,573
|
$25,892,000 | — | 30 Sep 2021 | |
| Bellevue Group AG |
13F
|
Company |
1.5%
|
752,945
|
$24,817,000 | — | 30 Sep 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.1%
|
539,057
|
$17,767,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
491,430
|
$16,197,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1%
|
491,257
|
$14,600,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
0.87%
|
423,342
|
$13,954,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.75%
|
365,968
|
$12,062,000 | — | 30 Sep 2021 | |
| York State Teachers Retirement System New |
13F
|
Individual |
0.66%
|
323,557
|
$10,664,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.63%
|
308,067
|
$10,154,000 | — | 30 Sep 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.6%
|
293,332
|
$9,668,000 | — | 30 Sep 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.6%
|
292,555
|
$9,643,000 | — | 30 Sep 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.57%
|
277,640
|
$9,151,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
277,250
|
$9,139,000 | — | 30 Sep 2021 | |
| WMS Partners, LLC |
13F
|
Company |
0.51%
|
250,000
|
$8,240,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.42%
|
204,052
|
$6,726,000 | — | 30 Sep 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.41%
|
198,245
|
$6,534,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.39%
|
192,329
|
$6,339,000 | — | 30 Sep 2021 | |
| Fairmount Funds Management LLC |
13F
|
Company |
0.38%
|
187,598
|
$6,183,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.34%
|
167,792
|
$5,530,000 | — | 30 Sep 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.31%
|
153,602
|
$5,063,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
146,406
|
$4,827,000 | — | 30 Sep 2021 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.3%
|
145,792
|
$4,808,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.28%
|
137,325
|
$4,526,000 | — | 30 Sep 2021 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
115,939
|
$3,821,000 | — | 30 Sep 2021 | |
| MORGAN JESS S & CO INC |
13F
|
Company |
0.23%
|
113,430
|
$3,739,000 | — | 30 Sep 2021 | |
| MPM BioImpact LLC |
13F
|
Company |
0.23%
|
110,155
|
$3,631,000 | — | 30 Sep 2021 | |
| Beck Bode, LLC |
13F
|
Company |
0.21%
|
102,127
|
$3,366,000 | — | 30 Sep 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.2%
|
98,582
|
$3,249,000 | — | 30 Sep 2021 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.18%
|
90,329
|
$2,977,000 | — | 30 Sep 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.17%
|
83,066
|
$2,738,000 | — | 30 Sep 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.16%
|
80,420
|
$2,651,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.16%
|
80,227
|
$2,645,000 | — | 30 Sep 2021 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.16%
|
80,211
|
$2,644,000 | — | 30 Sep 2021 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
73,969
|
$2,438,000 | — | 30 Sep 2021 | |
| Caption Management, LLC |
13F
|
Company |
0.14%
|
69,000
|
$2,274,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
53,500
|
$1,763,000 | — | 30 Sep 2021 | |
| Endurant Capital Management LP |
13F
|
Company |
0.11%
|
52,048
|
$1,716,000 | — | 30 Sep 2021 | |
| MOODY ALDRICH PARTNERS LLC |
13F
|
Company |
0.1%
|
50,894
|
$1,677,000 | — | 30 Sep 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.1%
|
47,284
|
$1,558,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
46,871
|
$1,545,000 | — | 30 Sep 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.09%
|
44,509
|
$1,467,000 | — | 30 Sep 2021 | |
| Walleye Trading LLC |
13F
|
Company |
0.09%
|
44,440
|
$1,465,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
43,709
|
$1,440,000 | — | 30 Sep 2021 | |
| Employees Retirement System of Texas |
13F
|
Company |
0.09%
|
42,000
|
$1,384,000 | — | 30 Sep 2021 | |
| BALDWIN WEALTH PARTNERS LLC/MA |
13F
|
Company |
0.09%
|
41,845
|
$1,379,000 | — | 30 Sep 2021 |
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q4 2021
As of 31 Dec 2021,
Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,632,401 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., RTW INVESTMENTS, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Avidity Partners Management LP, STATE STREET CORP, Bellevue Group AG, BAKER BROS. ADVISORS LP, IRIDIAN ASSET MANAGEMENT LLC/CT, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
161
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
165
Q4 2021 holders
161
Holder diff
-4
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.